Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Kala Pharmaceuticals Inc Developer of products that penetrate the mucosal barrier to treat a variety of severe diseases |
United States | 28 Feb 2013 | Series A Active |